

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.13244023 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 4.15692544 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 4.15692544 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.15692544 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.15692544 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.15692544 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 4.15692544 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.05434192 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 3.85824710 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.78279850 |
| 11 | negative regulation of cell killing (GO:0031342) | 3.75457833 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.75457833 |
| 13 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.64464104 |
| 14 | response to peptidoglycan (GO:0032494) | 3.64303401 |
| 15 | cellular extravasation (GO:0045123) | 3.56502582 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 3.40593494 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 3.39113163 |
| 18 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.31829592 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 3.29744192 |
| 20 | regulation of leukocyte degranulation (GO:0043300) | 3.27907101 |
| 21 | detection of other organism (GO:0098543) | 3.26418285 |
| 22 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.24937438 |
| 23 | protein localization to endosome (GO:0036010) | 3.15249857 |
| 24 | regulation of mast cell degranulation (GO:0043304) | 3.13598606 |
| 25 | regulation of early endosome to late endosome transport (GO:2000641) | 3.09983570 |
| 26 | lysine metabolic process (GO:0006553) | 3.08033333 |
| 27 | lysine catabolic process (GO:0006554) | 3.08033333 |
| 28 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.06259294 |
| 29 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.05531538 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05009345 |
| 31 | positive regulation of mast cell activation (GO:0033005) | 3.03850816 |
| 32 | fatty acid transmembrane transport (GO:1902001) | 3.01112841 |
| 33 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.99430073 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98535230 |
| 35 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.97539933 |
| 36 | detection of external biotic stimulus (GO:0098581) | 2.96863675 |
| 37 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.96230344 |
| 38 | response to muramyl dipeptide (GO:0032495) | 2.95024993 |
| 39 | detection of bacterium (GO:0016045) | 2.89930033 |
| 40 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.89891117 |
| 41 | positive regulation of receptor recycling (GO:0001921) | 2.88972333 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 2.88899913 |
| 43 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.88694742 |
| 44 | regulation of regulated secretory pathway (GO:1903305) | 2.87688250 |
| 45 | hypotonic response (GO:0006971) | 2.84825175 |
| 46 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.82926657 |
| 47 | positive regulation of fatty acid oxidation (GO:0046321) | 2.81671846 |
| 48 | response to host (GO:0075136) | 2.81460227 |
| 49 | response to host defenses (GO:0052200) | 2.81460227 |
| 50 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.81460227 |
| 51 | layer formation in cerebral cortex (GO:0021819) | 2.81225950 |
| 52 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.77833814 |
| 53 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.75944330 |
| 54 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.75628420 |
| 55 | response to host immune response (GO:0052572) | 2.75628420 |
| 56 | plasma membrane repair (GO:0001778) | 2.74801307 |
| 57 | positive regulation of leukocyte degranulation (GO:0043302) | 2.73341154 |
| 58 | locomotory exploration behavior (GO:0035641) | 2.71669696 |
| 59 | regulation of platelet aggregation (GO:0090330) | 2.71474343 |
| 60 | detection of biotic stimulus (GO:0009595) | 2.70204321 |
| 61 | carnitine shuttle (GO:0006853) | 2.69552537 |
| 62 | positive regulation of regulated secretory pathway (GO:1903307) | 2.68547953 |
| 63 | positive regulation of lipid catabolic process (GO:0050996) | 2.68255209 |
| 64 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.67557404 |
| 65 | macrophage activation (GO:0042116) | 2.67090207 |
| 66 | low-density lipoprotein particle clearance (GO:0034383) | 2.66832308 |
| 67 | response to laminar fluid shear stress (GO:0034616) | 2.66155426 |
| 68 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.64338413 |
| 69 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.62504812 |
| 70 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.61874857 |
| 71 | regulation of ARF GTPase activity (GO:0032312) | 2.61222353 |
| 72 | negative regulation of interleukin-12 production (GO:0032695) | 2.60951793 |
| 73 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.60719051 |
| 74 | histone H3-K9 demethylation (GO:0033169) | 2.59893530 |
| 75 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.56060614 |
| 76 | positive regulation of Rap GTPase activity (GO:0032854) | 2.54990305 |
| 77 | synaptic vesicle maturation (GO:0016188) | 2.54738814 |
| 78 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.54334387 |
| 79 | megakaryocyte development (GO:0035855) | 2.54191045 |
| 80 | regulation of macrophage cytokine production (GO:0010935) | 2.53826389 |
| 81 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.53755329 |
| 82 | positive regulation of mast cell degranulation (GO:0043306) | 2.53755329 |
| 83 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.53473698 |
| 84 | protein carboxylation (GO:0018214) | 2.53473698 |
| 85 | myeloid cell activation involved in immune response (GO:0002275) | 2.53127843 |
| 86 | 2-oxoglutarate metabolic process (GO:0006103) | 2.49542378 |
| 87 | microglial cell activation (GO:0001774) | 2.48510622 |
| 88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.48182677 |
| 89 | L-phenylalanine catabolic process (GO:0006559) | 2.48182677 |
| 90 | negative regulation of fibrinolysis (GO:0051918) | 2.47523502 |
| 91 | cortical actin cytoskeleton organization (GO:0030866) | 2.45531802 |
| 92 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.44823970 |
| 93 | peptide catabolic process (GO:0043171) | 2.44454234 |
| 94 | regulation of fatty acid oxidation (GO:0046320) | 2.44110513 |
| 95 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.43876206 |
| 96 | complement activation, alternative pathway (GO:0006957) | 2.43597797 |
| 97 | cysteine metabolic process (GO:0006534) | 2.43204650 |
| 98 | glutamate metabolic process (GO:0006536) | 2.43147581 |
| 99 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.42899964 |
| 100 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.42623038 |
| 101 | negative regulation of inclusion body assembly (GO:0090084) | 2.41156613 |
| 102 | neutrophil activation (GO:0042119) | 2.41053214 |
| 103 | regulation of cholesterol homeostasis (GO:2000188) | 2.40382369 |
| 104 | activation of protein kinase A activity (GO:0034199) | 2.40193811 |
| 105 | histone H3-K36 demethylation (GO:0070544) | 2.39033074 |
| 106 | apoptotic cell clearance (GO:0043277) | 2.38854244 |
| 107 | germinal center formation (GO:0002467) | 2.38102910 |
| 108 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.37914998 |
| 109 | leukocyte aggregation (GO:0070486) | 2.37141727 |
| 110 | L-phenylalanine metabolic process (GO:0006558) | 2.36665407 |
| 111 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.36665407 |
| 112 | negative regulation of heart growth (GO:0061117) | 2.34971619 |
| 113 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.34971619 |
| 114 | regulation of lipid kinase activity (GO:0043550) | 2.34536949 |
| 115 | midgut development (GO:0007494) | 2.34313327 |
| 116 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.34162068 |
| 117 | plasma lipoprotein particle clearance (GO:0034381) | 2.33502591 |
| 118 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.33480479 |
| 119 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.33166718 |
| 120 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.31935295 |
| 121 | signal complex assembly (GO:0007172) | 2.31362989 |
| 122 | growth hormone receptor signaling pathway (GO:0060396) | 2.31198205 |
| 123 | pinocytosis (GO:0006907) | 2.31046974 |
| 124 | definitive hemopoiesis (GO:0060216) | 2.30987235 |
| 125 | negative regulation of cell size (GO:0045792) | 2.29990748 |
| 126 | regulation of cholesterol storage (GO:0010885) | 2.29821230 |
| 127 | mannose metabolic process (GO:0006013) | 2.29769613 |
| 128 | adenosine receptor signaling pathway (GO:0001973) | 2.28431315 |
| 129 | acylglycerol catabolic process (GO:0046464) | 2.28309214 |
| 130 | neutral lipid catabolic process (GO:0046461) | 2.28309214 |
| 131 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.28283606 |
| 132 | B cell receptor signaling pathway (GO:0050853) | 2.28224790 |
| 133 | cellular ketone body metabolic process (GO:0046950) | 2.27050837 |
| 134 | regulation of mast cell activation (GO:0033003) | 2.26942369 |
| 135 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.26725397 |
| 136 | positive regulation of glycogen metabolic process (GO:0070875) | 2.26547764 |
| 137 | urea cycle (GO:0000050) | 2.25999923 |
| 138 | urea metabolic process (GO:0019627) | 2.25999923 |
| 139 | phospholipid homeostasis (GO:0055091) | 2.25918023 |
| 140 | positive regulation of type 2 immune response (GO:0002830) | 2.25885633 |
| 141 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.25830390 |
| 142 | granulocyte activation (GO:0036230) | 2.25136645 |
| 143 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.23661597 |
| 144 | nerve growth factor signaling pathway (GO:0038180) | 2.22554628 |
| 145 | positive regulation of myotube differentiation (GO:0010831) | 2.22022662 |
| 146 | leukocyte degranulation (GO:0043299) | 2.21553043 |
| 147 | endothelium development (GO:0003158) | 2.20599778 |
| 148 | negative regulation of type 2 immune response (GO:0002829) | 2.20337848 |
| 149 | stress fiber assembly (GO:0043149) | 2.19661473 |
| 150 | angiogenesis involved in wound healing (GO:0060055) | 2.19587308 |
| 151 | negative regulation of fatty acid transport (GO:2000192) | 2.19408907 |
| 152 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.19065527 |
| 153 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.18589668 |
| 154 | cell adhesion mediated by integrin (GO:0033627) | 2.18370846 |
| 155 | response to thyroid hormone (GO:0097066) | 2.18015150 |
| 156 | kynurenine metabolic process (GO:0070189) | 2.18014598 |
| 157 | blood vessel endothelial cell migration (GO:0043534) | 2.17855811 |
| 158 | protein targeting to Golgi (GO:0000042) | 2.17832445 |
| 159 | regulation of ARF protein signal transduction (GO:0032012) | 2.17418646 |
| 160 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.17142746 |
| 161 | aspartate family amino acid catabolic process (GO:0009068) | 2.17002295 |
| 162 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.16808376 |
| 163 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.16485805 |
| 164 | carnitine transmembrane transport (GO:1902603) | 2.16390895 |
| 165 | sulfur amino acid catabolic process (GO:0000098) | 2.16228254 |
| 166 | bile acid biosynthetic process (GO:0006699) | 2.15966096 |
| 167 | 4-hydroxyproline metabolic process (GO:0019471) | 2.15570233 |
| 168 | regulation of protein activation cascade (GO:2000257) | 2.15307571 |
| 169 | sodium ion export (GO:0071436) | 2.15259101 |
| 170 | positive regulation of glycolytic process (GO:0045821) | 2.13505475 |
| 171 | glyoxylate metabolic process (GO:0046487) | 2.13415610 |
| 172 | positive regulation of histone deacetylation (GO:0031065) | 2.13219023 |
| 173 | establishment of protein localization to Golgi (GO:0072600) | 2.13199678 |
| 174 | regulation of fibrinolysis (GO:0051917) | 2.13014219 |
| 175 | establishment of nucleus localization (GO:0040023) | 2.12990385 |
| 176 | carnitine transport (GO:0015879) | 2.11246116 |
| 177 | amino-acid betaine transport (GO:0015838) | 2.11246116 |
| 178 | regulation of sequestering of triglyceride (GO:0010889) | 2.11032761 |
| 179 | intracellular lipid transport (GO:0032365) | 2.10897248 |
| 180 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.10492495 |
| 181 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.09916214 |
| 182 | cell communication by electrical coupling (GO:0010644) | 2.09864815 |
| 183 | cellular modified amino acid catabolic process (GO:0042219) | 2.09655270 |
| 184 | negative regulation of vascular permeability (GO:0043116) | 2.09094280 |
| 185 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.08607952 |
| 186 | homocysteine metabolic process (GO:0050667) | 2.08546182 |
| 187 | short-chain fatty acid metabolic process (GO:0046459) | 2.08357730 |
| 188 | epoxygenase P450 pathway (GO:0019373) | 2.08317364 |
| 189 | triglyceride catabolic process (GO:0019433) | 2.07706300 |
| 190 | adherens junction assembly (GO:0034333) | 2.07674378 |
| 191 | regulation of lipid catabolic process (GO:0050994) | 2.06862299 |
| 192 | regulation of triglyceride catabolic process (GO:0010896) | 2.05026216 |
| 193 | regulation of complement activation (GO:0030449) | 2.04842919 |
| 194 | negative regulation of lipid transport (GO:0032369) | 2.03496758 |
| 195 | endoplasmic reticulum organization (GO:0007029) | 2.03140769 |
| 196 | valine metabolic process (GO:0006573) | 2.02201862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.63466303 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68428951 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.67426218 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.61087259 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.57060236 |
| 6 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.50871052 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31545436 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.29242474 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.28348782 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25752156 |
| 11 | SPI1_23127762_ChIP-Seq_K562_Human | 2.21585001 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.21062666 |
| 13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.18904230 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.15182114 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.13954134 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.04030699 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.03544286 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.02245112 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01832733 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.00483374 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.98755273 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 1.89983759 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89218302 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85025845 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.84672670 |
| 26 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.83870190 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.81256886 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81181635 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77858251 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.75112541 |
| 31 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.74443619 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72061200 |
| 33 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.67814010 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.66364524 |
| 35 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.65456975 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.63425680 |
| 37 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.60795086 |
| 38 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.58527217 |
| 39 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.57660692 |
| 40 | * MAF_26560356_Chip-Seq_TH1_Human | 1.56858215 |
| 41 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.53371144 |
| 42 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.52767178 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.52218897 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51137732 |
| 45 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.50904529 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.48541917 |
| 47 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45958905 |
| 48 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44214927 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43354057 |
| 50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42021578 |
| 51 | GATA2_19941826_ChIP-Seq_K562_Human | 1.41917246 |
| 52 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40619483 |
| 53 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.40534123 |
| 54 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39352771 |
| 55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39139610 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39049847 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.37104974 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36196890 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35687478 |
| 60 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.34919847 |
| 61 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.34144496 |
| 62 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.34144496 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31174371 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30669427 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29437228 |
| 66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.29141110 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28784427 |
| 68 | TP53_16413492_ChIP-PET_HCT116_Human | 1.28655755 |
| 69 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27308400 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27157337 |
| 71 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.26731332 |
| 72 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25921008 |
| 73 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24051721 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23663762 |
| 75 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.22588036 |
| 76 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.22588036 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.22565632 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.22565632 |
| 79 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.22340311 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22238978 |
| 81 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21693818 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21621041 |
| 83 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.21017850 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20021132 |
| 85 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.19439373 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19258484 |
| 87 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.19020436 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18167799 |
| 89 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.17357262 |
| 90 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16285989 |
| 91 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15258489 |
| 92 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.15243948 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15133149 |
| 94 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14999124 |
| 95 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.14375134 |
| 96 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13660760 |
| 97 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12856915 |
| 98 | MYB_26560356_Chip-Seq_TH2_Human | 1.11813386 |
| 99 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11636023 |
| 100 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11110725 |
| 101 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10066164 |
| 102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09414269 |
| 103 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09370865 |
| 104 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08943402 |
| 105 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.07755377 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07090109 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07082146 |
| 108 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06111877 |
| 109 | MYB_26560356_Chip-Seq_TH1_Human | 1.06015153 |
| 110 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05601805 |
| 111 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.05593451 |
| 112 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05211530 |
| 113 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04988117 |
| 114 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.03545982 |
| 115 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03416584 |
| 116 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03266685 |
| 117 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03204904 |
| 118 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02830625 |
| 119 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02556415 |
| 120 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.02375130 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02335977 |
| 122 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02186412 |
| 123 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01049504 |
| 124 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.00787205 |
| 125 | * MAF_26560356_Chip-Seq_TH2_Human | 1.00658391 |
| 126 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00233903 |
| 127 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99443650 |
| 128 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99167719 |
| 129 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98639617 |
| 130 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98205139 |
| 131 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98127696 |
| 132 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97954396 |
| 133 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97849754 |
| 134 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97786637 |
| 135 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.97295913 |
| 136 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96887617 |
| 137 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96214166 |
| 138 | CJUN_26792858_Chip-Seq_BT549_Human | 0.95620332 |
| 139 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95570712 |
| 140 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95516599 |
| 141 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95363904 |
| 142 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94762621 |
| 143 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94728366 |
| 144 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94577519 |
| 145 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93853916 |
| 146 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93520954 |
| 147 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92745226 |
| 148 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92660117 |
| 149 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.92612347 |
| 150 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92574085 |
| 151 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.91886072 |
| 152 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.91803590 |
| 153 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90859815 |
| 154 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90620539 |
| 155 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90619128 |
| 156 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90157281 |
| 157 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90067400 |
| 158 | AR_19668381_ChIP-Seq_PC3_Human | 0.89807140 |
| 159 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89656567 |
| 160 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.89240159 |
| 161 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.88781493 |
| 162 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.88500434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.59322354 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.56327971 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.45537064 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.14904125 |
| 5 | MP0005464_abnormal_platelet_physiology | 3.10892389 |
| 6 | MP0003724_increased_susceptibility_to | 2.95150093 |
| 7 | MP0003436_decreased_susceptibility_to | 2.88166032 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.85425352 |
| 9 | MP0004130_abnormal_muscle_cell | 2.81510804 |
| 10 | MP0005365_abnormal_bile_salt | 2.66346149 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.46715918 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.43479132 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.41205408 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.36636620 |
| 15 | MP0005409_darkened_coat_color | 2.36556380 |
| 16 | MP0005451_abnormal_body_composition | 2.22593554 |
| 17 | MP0004185_abnormal_adipocyte_glucose | 2.16913000 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.13429669 |
| 19 | MP0003252_abnormal_bile_duct | 2.11776119 |
| 20 | MP0005167_abnormal_blood-brain_barrier | 2.09716926 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 2.03713766 |
| 22 | MP0002419_abnormal_innate_immunity | 2.00467625 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 2.00235386 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.98016438 |
| 25 | MP0000013_abnormal_adipose_tissue | 1.86971196 |
| 26 | MP0008260_abnormal_autophagy | 1.86536959 |
| 27 | MP0010368_abnormal_lymphatic_system | 1.86358496 |
| 28 | MP0003303_peritoneal_inflammation | 1.84075588 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.80372847 |
| 30 | MP0005410_abnormal_fertilization | 1.69603439 |
| 31 | MP0008961_abnormal_basal_metabolism | 1.69462163 |
| 32 | MP0004272_abnormal_basement_membrane | 1.65934639 |
| 33 | MP0004084_abnormal_cardiac_muscle | 1.64369712 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.61038459 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.59030228 |
| 36 | MP0008004_abnormal_stomach_pH | 1.57662378 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.56542136 |
| 38 | MP0009278_abnormal_bone_marrow | 1.54737567 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.54229637 |
| 40 | MP0000751_myopathy | 1.52879437 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.52218548 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.51893531 |
| 43 | MP0004947_skin_inflammation | 1.50080325 |
| 44 | MP0001851_eye_inflammation | 1.48305368 |
| 45 | MP0005025_abnormal_response_to | 1.47894524 |
| 46 | MP0004883_abnormal_blood_vessel | 1.44970965 |
| 47 | MP0000537_abnormal_urethra_morphology | 1.43458794 |
| 48 | MP0005187_abnormal_penis_morphology | 1.41780178 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.41003629 |
| 50 | MP0004087_abnormal_muscle_fiber | 1.40281074 |
| 51 | MP0005375_adipose_tissue_phenotype | 1.38980940 |
| 52 | MP0004510_myositis | 1.38324497 |
| 53 | MP0005623_abnormal_meninges_morphology | 1.36933918 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.36569941 |
| 55 | MP0002009_preneoplasia | 1.35683977 |
| 56 | MP0002132_abnormal_respiratory_system | 1.35538028 |
| 57 | MP0004808_abnormal_hematopoietic_stem | 1.34746234 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.34658912 |
| 59 | MP0004036_abnormal_muscle_relaxation | 1.34597708 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.34499399 |
| 61 | MP0006082_CNS_inflammation | 1.34119019 |
| 62 | MP0000604_amyloidosis | 1.33003457 |
| 63 | MP0003566_abnormal_cell_adhesion | 1.31882151 |
| 64 | MP0003279_aneurysm | 1.31542595 |
| 65 | MP0000003_abnormal_adipose_tissue | 1.31047037 |
| 66 | MP0002420_abnormal_adaptive_immunity | 1.29810301 |
| 67 | MP0003195_calcinosis | 1.29409010 |
| 68 | MP0002723_abnormal_immune_serum | 1.29069737 |
| 69 | MP0001819_abnormal_immune_cell | 1.27909522 |
| 70 | MP0004484_altered_response_of | 1.27752270 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 1.26792499 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 1.26609767 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.26609767 |
| 74 | MP0000858_altered_metastatic_potential | 1.26158804 |
| 75 | MP0003690_abnormal_glial_cell | 1.26006554 |
| 76 | MP0002896_abnormal_bone_mineralization | 1.25329134 |
| 77 | MP0001800_abnormal_humoral_immune | 1.24220299 |
| 78 | MP0002452_abnormal_antigen_presenting | 1.23989033 |
| 79 | MP0000747_muscle_weakness | 1.22182325 |
| 80 | MP0005330_cardiomyopathy | 1.21985360 |
| 81 | MP0003329_amyloid_beta_deposits | 1.21857001 |
| 82 | MP0009384_cardiac_valve_regurgitation | 1.21331612 |
| 83 | MP0005164_abnormal_response_to | 1.19719639 |
| 84 | MP0000685_abnormal_immune_system | 1.19225485 |
| 85 | MP0002398_abnormal_bone_marrow | 1.18273209 |
| 86 | MP0003045_fibrosis | 1.18250719 |
| 87 | MP0000767_abnormal_smooth_muscle | 1.18038082 |
| 88 | MP0004215_abnormal_myocardial_fiber | 1.17589452 |
| 89 | MP0001666_abnormal_nutrient_absorption | 1.17411887 |
| 90 | MP0003448_altered_tumor_morphology | 1.17093457 |
| 91 | MP0001879_abnormal_lymphatic_vessel | 1.14566330 |
| 92 | MP0003075_altered_response_to | 1.14545753 |
| 93 | MP0005332_abnormal_amino_acid | 1.14076290 |
| 94 | MP0001915_intracranial_hemorrhage | 1.13885605 |
| 95 | MP0001790_abnormal_immune_system | 1.13444046 |
| 96 | MP0005387_immune_system_phenotype | 1.13444046 |
| 97 | MP0000609_abnormal_liver_physiology | 1.12977925 |
| 98 | MP0002971_abnormal_brown_adipose | 1.11101385 |
| 99 | MP0005275_abnormal_skin_tensile | 1.10673155 |
| 100 | MP0005620_abnormal_muscle_contractility | 1.10332955 |
| 101 | MP0002396_abnormal_hematopoietic_system | 1.08057473 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 1.07484196 |
| 103 | MP0003091_abnormal_cell_migration | 1.06742748 |
| 104 | MP0010630_abnormal_cardiac_muscle | 1.06727113 |
| 105 | MP0002405_respiratory_system_inflammati | 1.06385960 |
| 106 | MP0010155_abnormal_intestine_physiology | 1.06338025 |
| 107 | MP0005083_abnormal_biliary_tract | 1.06088864 |
| 108 | MP0005248_abnormal_Harderian_gland | 1.05997342 |
| 109 | MP0003868_abnormal_feces_composition | 1.05733061 |
| 110 | MP0000249_abnormal_blood_vessel | 1.05724570 |
| 111 | MP0002972_abnormal_cardiac_muscle | 1.04902994 |
| 112 | MP0003763_abnormal_thymus_physiology | 1.04878643 |
| 113 | MP0000343_altered_response_to | 1.04630793 |
| 114 | MP0001348_abnormal_lacrimal_gland | 1.04277188 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 1.03003418 |
| 116 | MP0000733_abnormal_muscle_development | 1.00188643 |
| 117 | MP0003635_abnormal_synaptic_transmissio | 0.99488341 |
| 118 | MP0000716_abnormal_immune_system | 0.98904998 |
| 119 | MP0004858_abnormal_nervous_system | 0.97987915 |
| 120 | MP0008775_abnormal_heart_ventricle | 0.97495174 |
| 121 | MP0003828_pulmonary_edema | 0.97081357 |
| 122 | MP0005670_abnormal_white_adipose | 0.97077878 |
| 123 | MP0005310_abnormal_salivary_gland | 0.96615607 |
| 124 | MP0004145_abnormal_muscle_electrophysio | 0.96579499 |
| 125 | MP0004270_analgesia | 0.95914116 |
| 126 | MP0001849_ear_inflammation | 0.92173869 |
| 127 | MP0003633_abnormal_nervous_system | 0.91993730 |
| 128 | MP0006138_congestive_heart_failure | 0.91984546 |
| 129 | MP0002722_abnormal_immune_system | 0.89565703 |
| 130 | MP0000569_abnormal_digit_pigmentation | 0.89479227 |
| 131 | MP0002166_altered_tumor_susceptibility | 0.89253406 |
| 132 | MP0005023_abnormal_wound_healing | 0.88733995 |
| 133 | MP0000703_abnormal_thymus_morphology | 0.88017569 |
| 134 | MP0005385_cardiovascular_system_phenoty | 0.87911362 |
| 135 | MP0001544_abnormal_cardiovascular_syste | 0.87911362 |
| 136 | MP0010352_gastrointestinal_tract_polyps | 0.87739218 |
| 137 | MP0002269_muscular_atrophy | 0.87518012 |
| 138 | MP0002078_abnormal_glucose_homeostasis | 0.86895118 |
| 139 | MP0000749_muscle_degeneration | 0.86721228 |
| 140 | MP0008874_decreased_physiological_sensi | 0.86375703 |
| 141 | MP0002429_abnormal_blood_cell | 0.85621000 |
| 142 | MP0002133_abnormal_respiratory_system | 0.85387074 |
| 143 | MP0005388_respiratory_system_phenotype | 0.85387074 |
| 144 | MP0005535_abnormal_body_temperature | 0.85265667 |
| 145 | MP0010678_abnormal_skin_adnexa | 0.85111822 |
| 146 | MP0000678_abnormal_parathyroid_gland | 0.84752847 |
| 147 | MP0005166_decreased_susceptibility_to | 0.84624573 |
| 148 | MP0009785_altered_susceptibility_to | 0.84506703 |
| 149 | MP0001845_abnormal_inflammatory_respons | 0.84424581 |
| 150 | MP0009840_abnormal_foam_cell | 0.84021846 |
| 151 | MP0005319_abnormal_enzyme/_coenzyme | 0.83144871 |
| 152 | MP0001958_emphysema | 0.82858288 |
| 153 | MP0002148_abnormal_hypersensitivity_rea | 0.82767539 |
| 154 | MP0009115_abnormal_fat_cell | 0.81121408 |
| 155 | MP0004085_abnormal_heartbeat | 0.80655258 |
| 156 | MP0002063_abnormal_learning/memory/cond | 0.80523074 |
| 157 | MP0003172_abnormal_lysosome_physiology | 0.79719533 |
| 158 | MP0003879_abnormal_hair_cell | 0.79464709 |
| 159 | MP0001614_abnormal_blood_vessel | 0.79427589 |
| 160 | MP0000759_abnormal_skeletal_muscle | 0.77252666 |
| 161 | MP0005390_skeleton_phenotype | 0.76329278 |
| 162 | MP0009053_abnormal_anal_canal | 0.75851422 |
| 163 | MP0001299_abnormal_eye_distance/ | 0.75067658 |
| 164 | MP0006054_spinal_hemorrhage | 0.73715572 |
| 165 | MP0002090_abnormal_vision | 0.73352094 |
| 166 | MP0002168_other_aberrant_phenotype | 0.72980513 |
| 167 | MP0002128_abnormal_blood_circulation | 0.72251696 |
| 168 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71770777 |
| 169 | MP0005334_abnormal_fat_pad | 0.70886023 |
| 170 | MP0002295_abnormal_pulmonary_circulatio | 0.69600122 |
| 171 | MP0004233_abnormal_muscle_weight | 0.67007929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.93046130 |
| 2 | Deep venous thrombosis (HP:0002625) | 3.87752565 |
| 3 | Prolonged bleeding time (HP:0003010) | 3.70113354 |
| 4 | Spontaneous hematomas (HP:0007420) | 3.64701264 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.29552742 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.29313688 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.26839441 |
| 8 | Abnormal platelet volume (HP:0011876) | 3.00510883 |
| 9 | Subacute progressive viral hepatitis (HP:0006572) | 2.96110008 |
| 10 | Peritonitis (HP:0002586) | 2.95267024 |
| 11 | Epistaxis (HP:0000421) | 2.86154456 |
| 12 | Lymphangioma (HP:0100764) | 2.84226760 |
| 13 | Xanthomatosis (HP:0000991) | 2.82272835 |
| 14 | Gingival bleeding (HP:0000225) | 2.79854469 |
| 15 | Abnormality of the Achilles tendon (HP:0005109) | 2.76668670 |
| 16 | Menorrhagia (HP:0000132) | 2.73449010 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72691059 |
| 18 | Increased mean platelet volume (HP:0011877) | 2.72023165 |
| 19 | Papilledema (HP:0001085) | 2.71424093 |
| 20 | Purpura (HP:0000979) | 2.64819004 |
| 21 | Cerebral aneurysm (HP:0004944) | 2.62189966 |
| 22 | Achilles tendon contracture (HP:0001771) | 2.60922682 |
| 23 | Vascular tortuosity (HP:0004948) | 2.57040301 |
| 24 | Complement deficiency (HP:0004431) | 2.54800871 |
| 25 | Gingivitis (HP:0000230) | 2.52345720 |
| 26 | Hyporeflexia of lower limbs (HP:0002600) | 2.51711328 |
| 27 | Exercise-induced muscle cramps (HP:0003710) | 2.51289054 |
| 28 | Hypoglycemic coma (HP:0001325) | 2.49049855 |
| 29 | Mitral valve prolapse (HP:0001634) | 2.44297232 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 2.43634345 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 2.41113934 |
| 32 | Ketoacidosis (HP:0001993) | 2.40829840 |
| 33 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.38274539 |
| 34 | Ketosis (HP:0001946) | 2.37677063 |
| 35 | Myositis (HP:0100614) | 2.37127636 |
| 36 | Amyloidosis (HP:0011034) | 2.35764759 |
| 37 | Hematochezia (HP:0002573) | 2.34960769 |
| 38 | Cellulitis (HP:0100658) | 2.34761404 |
| 39 | Intrahepatic cholestasis (HP:0001406) | 2.33902749 |
| 40 | Difficulty running (HP:0009046) | 2.31660075 |
| 41 | Macroorchidism (HP:0000053) | 2.29918145 |
| 42 | Orchitis (HP:0100796) | 2.24766221 |
| 43 | Myocardial infarction (HP:0001658) | 2.23451134 |
| 44 | Sudden death (HP:0001699) | 2.22701522 |
| 45 | Hyperlipoproteinemia (HP:0010980) | 2.20745299 |
| 46 | Epidermoid cyst (HP:0200040) | 2.19553558 |
| 47 | Protrusio acetabuli (HP:0003179) | 2.19114105 |
| 48 | Exercise-induced myalgia (HP:0003738) | 2.18613009 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.18224275 |
| 50 | Obstructive lung disease (HP:0006536) | 2.18224275 |
| 51 | Myoglobinuria (HP:0002913) | 2.17825111 |
| 52 | Skin nodule (HP:0200036) | 2.17192193 |
| 53 | Increased connective tissue (HP:0009025) | 2.16205241 |
| 54 | Obstructive sleep apnea (HP:0002870) | 2.13054218 |
| 55 | Aortic aneurysm (HP:0004942) | 2.12212431 |
| 56 | Spondylolisthesis (HP:0003302) | 2.11332778 |
| 57 | Abnormality of the common coagulation pathway (HP:0010990) | 2.09720889 |
| 58 | Aneurysm (HP:0002617) | 2.07831723 |
| 59 | Termporal pattern (HP:0011008) | 2.07644872 |
| 60 | Insidious onset (HP:0003587) | 2.07644872 |
| 61 | Hepatocellular carcinoma (HP:0001402) | 2.05067794 |
| 62 | Cerebral inclusion bodies (HP:0100314) | 2.04545554 |
| 63 | Abnormal platelet function (HP:0011869) | 2.04006689 |
| 64 | Impaired platelet aggregation (HP:0003540) | 2.04006689 |
| 65 | Dysostosis multiplex (HP:0000943) | 2.01398533 |
| 66 | Striae distensae (HP:0001065) | 1.98780209 |
| 67 | Broad metatarsal (HP:0001783) | 1.98484663 |
| 68 | Buphthalmos (HP:0000557) | 1.97450057 |
| 69 | Mitral stenosis (HP:0001718) | 1.97203902 |
| 70 | Enlarged penis (HP:0000040) | 1.95251900 |
| 71 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.94170077 |
| 72 | Recurrent skin infections (HP:0001581) | 1.94036849 |
| 73 | Retrobulbar optic neuritis (HP:0100654) | 1.93911328 |
| 74 | Optic neuritis (HP:0100653) | 1.93911328 |
| 75 | Arterial thrombosis (HP:0004420) | 1.92638885 |
| 76 | Asymmetric septal hypertrophy (HP:0001670) | 1.91874564 |
| 77 | Hypolipoproteinemia (HP:0010981) | 1.91805498 |
| 78 | Shallow orbits (HP:0000586) | 1.91465430 |
| 79 | Ankyloglossia (HP:0010296) | 1.90836604 |
| 80 | Dysmetric saccades (HP:0000641) | 1.90223663 |
| 81 | Abnormality of the lower motor neuron (HP:0002366) | 1.88418657 |
| 82 | Bundle branch block (HP:0011710) | 1.88218192 |
| 83 | Global brain atrophy (HP:0002283) | 1.86404654 |
| 84 | Distal lower limb amyotrophy (HP:0008944) | 1.86369152 |
| 85 | Type 1 muscle fiber predominance (HP:0003803) | 1.86053604 |
| 86 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85330685 |
| 87 | Visceral angiomatosis (HP:0100761) | 1.84932308 |
| 88 | Petechiae (HP:0000967) | 1.84874875 |
| 89 | Abnormality of the nasal mucosa (HP:0000433) | 1.84320490 |
| 90 | Slow saccadic eye movements (HP:0000514) | 1.84157575 |
| 91 | Difficulty climbing stairs (HP:0003551) | 1.83817103 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83766606 |
| 93 | Distal lower limb muscle weakness (HP:0009053) | 1.83507748 |
| 94 | Episodic fever (HP:0001954) | 1.83138332 |
| 95 | Polycythemia (HP:0001901) | 1.82902804 |
| 96 | Turricephaly (HP:0000262) | 1.82630529 |
| 97 | Esophageal varix (HP:0002040) | 1.82606755 |
| 98 | Increased variability in muscle fiber diameter (HP:0003557) | 1.82273272 |
| 99 | Fatigue (HP:0012378) | 1.81944373 |
| 100 | Calf muscle hypertrophy (HP:0008981) | 1.81762049 |
| 101 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.81280900 |
| 102 | Spinal cord lesions (HP:0100561) | 1.80588012 |
| 103 | Syringomyelia (HP:0003396) | 1.80588012 |
| 104 | Flat acetabular roof (HP:0003180) | 1.79499548 |
| 105 | Frequent falls (HP:0002359) | 1.78826020 |
| 106 | Long toe (HP:0010511) | 1.78820487 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 1.78310784 |
| 108 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.77733447 |
| 109 | Abnormal social behavior (HP:0012433) | 1.77327419 |
| 110 | Impaired social interactions (HP:0000735) | 1.77327419 |
| 111 | Right ventricular cardiomyopathy (HP:0011663) | 1.76704376 |
| 112 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.76524454 |
| 113 | Abnormality of complement system (HP:0005339) | 1.75747498 |
| 114 | Resting tremor (HP:0002322) | 1.75197867 |
| 115 | Hemangiomatosis (HP:0007461) | 1.74692443 |
| 116 | Lower limb amyotrophy (HP:0007210) | 1.74566389 |
| 117 | Hemorrhage of the eye (HP:0011885) | 1.74516523 |
| 118 | Bruising susceptibility (HP:0000978) | 1.74078854 |
| 119 | Dilatation of the ascending aorta (HP:0005111) | 1.73699045 |
| 120 | Abnormality of the fingertips (HP:0001211) | 1.72979998 |
| 121 | Spastic diplegia (HP:0001264) | 1.72184413 |
| 122 | Neurofibrillary tangles (HP:0002185) | 1.72167803 |
| 123 | Hyperglycemia (HP:0003074) | 1.72056620 |
| 124 | Chest pain (HP:0100749) | 1.71468701 |
| 125 | Gastrointestinal inflammation (HP:0004386) | 1.71238646 |
| 126 | Overgrowth (HP:0001548) | 1.70877563 |
| 127 | Abnormality of oral frenula (HP:0000190) | 1.70718313 |
| 128 | Disproportionate tall stature (HP:0001519) | 1.68918274 |
| 129 | Hamartoma of the eye (HP:0010568) | 1.68791611 |
| 130 | Distal upper limb amyotrophy (HP:0007149) | 1.68470682 |
| 131 | Upper limb amyotrophy (HP:0009129) | 1.68470682 |
| 132 | Pulmonary embolism (HP:0002204) | 1.68420420 |
| 133 | Increased CSF protein (HP:0002922) | 1.68335966 |
| 134 | Metaphyseal cupping (HP:0003021) | 1.68321168 |
| 135 | Hypoglycemic seizures (HP:0002173) | 1.67794883 |
| 136 | Thrombocytosis (HP:0001894) | 1.67654271 |
| 137 | Subaortic stenosis (HP:0001682) | 1.67424409 |
| 138 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.67424409 |
| 139 | Inflammation of the large intestine (HP:0002037) | 1.66816890 |
| 140 | Hyperammonemia (HP:0001987) | 1.66691803 |
| 141 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.65281587 |
| 142 | Decreased motor nerve conduction velocity (HP:0003431) | 1.65226753 |
| 143 | Scapular winging (HP:0003691) | 1.64929729 |
| 144 | Onion bulb formation (HP:0003383) | 1.63850991 |
| 145 | Bowel incontinence (HP:0002607) | 1.63669533 |
| 146 | Nasal polyposis (HP:0100582) | 1.63285222 |
| 147 | Broad face (HP:0000283) | 1.62721279 |
| 148 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.62333570 |
| 149 | Osteolytic defects of the hand bones (HP:0009699) | 1.62333570 |
| 150 | Aortic dissection (HP:0002647) | 1.62307285 |
| 151 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.61695719 |
| 152 | Meningitis (HP:0001287) | 1.61267691 |
| 153 | Osteomyelitis (HP:0002754) | 1.60815001 |
| 154 | Atrioventricular block (HP:0001678) | 1.60811319 |
| 155 | Abnormality of the calf musculature (HP:0001430) | 1.59979757 |
| 156 | Recurrent fungal infections (HP:0002841) | 1.59855154 |
| 157 | Colitis (HP:0002583) | 1.59432906 |
| 158 | Bronchomalacia (HP:0002780) | 1.59368385 |
| 159 | Hypercholesterolemia (HP:0003124) | 1.59051589 |
| 160 | Premature rupture of membranes (HP:0001788) | 1.58769614 |
| 161 | Polygenic inheritance (HP:0010982) | 1.57487032 |
| 162 | Thin bony cortex (HP:0002753) | 1.57327607 |
| 163 | Exostoses (HP:0100777) | 1.57143050 |
| 164 | Hypobetalipoproteinemia (HP:0003563) | 1.56717242 |
| 165 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.56599264 |
| 166 | Abnormal large intestine physiology (HP:0012700) | 1.56186696 |
| 167 | Mucopolysacchariduria (HP:0008155) | 1.55465002 |
| 168 | Action tremor (HP:0002345) | 1.55252036 |
| 169 | Arterial tortuosity (HP:0005116) | 1.55007953 |
| 170 | Abnormality of the intrinsic pathway (HP:0010989) | 1.54816211 |
| 171 | Postural instability (HP:0002172) | 1.54173493 |
| 172 | Back pain (HP:0003418) | 1.52720813 |
| 173 | Urinary urgency (HP:0000012) | 1.52327897 |
| 174 | Increased density of long bones (HP:0006392) | 1.51180666 |
| 175 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.50820473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.24979483 |
| 2 | PRPF4B | 3.53514734 |
| 3 | PKN2 | 3.48318173 |
| 4 | RIPK1 | 2.60172105 |
| 5 | MAP2K3 | 2.54879695 |
| 6 | TTN | 2.24546930 |
| 7 | SIK1 | 2.21233383 |
| 8 | KSR2 | 2.00282736 |
| 9 | MAP3K9 | 1.98064705 |
| 10 | PDGFRA | 1.97440885 |
| 11 | LATS1 | 1.85500278 |
| 12 | MAP3K2 | 1.80883035 |
| 13 | EPHA4 | 1.79470451 |
| 14 | NTRK3 | 1.75241199 |
| 15 | DMPK | 1.67555830 |
| 16 | FRK | 1.65259512 |
| 17 | ZAP70 | 1.61195447 |
| 18 | PTK6 | 1.59778201 |
| 19 | PRKD3 | 1.58284005 |
| 20 | BLK | 1.57908389 |
| 21 | INSRR | 1.57501860 |
| 22 | MAP3K10 | 1.50712552 |
| 23 | NTRK1 | 1.50351238 |
| 24 | SCYL2 | 1.48791033 |
| 25 | CAMKK1 | 1.47563470 |
| 26 | KSR1 | 1.44952162 |
| 27 | RET | 1.44711000 |
| 28 | FGFR2 | 1.43021763 |
| 29 | ERN1 | 1.42513170 |
| 30 | TYK2 | 1.39666306 |
| 31 | IRAK4 | 1.39619142 |
| 32 | BMPR2 | 1.33873977 |
| 33 | DAPK2 | 1.31558354 |
| 34 | CAMK1G | 1.26224577 |
| 35 | MAP3K14 | 1.26018428 |
| 36 | MAP3K3 | 1.24191603 |
| 37 | MARK2 | 1.21613425 |
| 38 | MAP3K6 | 1.19737853 |
| 39 | YES1 | 1.18843372 |
| 40 | FER | 1.15979533 |
| 41 | TIE1 | 1.15586764 |
| 42 | BTK | 1.15307374 |
| 43 | PDK4 | 1.14371530 |
| 44 | PDK3 | 1.14371530 |
| 45 | MOS | 1.13899352 |
| 46 | CAMK1D | 1.13179871 |
| 47 | HCK | 1.11136469 |
| 48 | MAP3K7 | 1.11104059 |
| 49 | PDGFRB | 1.09791006 |
| 50 | BMX | 1.09379419 |
| 51 | DDR2 | 1.09258543 |
| 52 | JAK3 | 1.08984912 |
| 53 | PAK6 | 1.07919633 |
| 54 | MAP2K4 | 1.07413546 |
| 55 | EEF2K | 1.07041916 |
| 56 | MAP4K1 | 1.06401671 |
| 57 | PIK3CG | 1.05789185 |
| 58 | SIK2 | 1.04667958 |
| 59 | TYRO3 | 1.04089280 |
| 60 | RIPK4 | 1.00657734 |
| 61 | FGFR3 | 1.00545939 |
| 62 | PRKCH | 1.00379749 |
| 63 | MAP3K4 | 0.97871934 |
| 64 | LRRK2 | 0.96985688 |
| 65 | PDPK1 | 0.96379382 |
| 66 | SMG1 | 0.96321104 |
| 67 | PTK2B | 0.94769752 |
| 68 | TAOK1 | 0.94732841 |
| 69 | PDK1 | 0.90509346 |
| 70 | FGFR4 | 0.89693103 |
| 71 | ICK | 0.89565238 |
| 72 | LMTK2 | 0.89185400 |
| 73 | IRAK3 | 0.88968791 |
| 74 | ARAF | 0.88354496 |
| 75 | PTK2 | 0.88331882 |
| 76 | IRAK2 | 0.88201628 |
| 77 | PAK3 | 0.87923727 |
| 78 | SGK3 | 0.85086406 |
| 79 | CDK6 | 0.84695755 |
| 80 | ALK | 0.84369790 |
| 81 | TGFBR2 | 0.83854966 |
| 82 | SGK2 | 0.82905286 |
| 83 | SYK | 0.82176803 |
| 84 | MINK1 | 0.81602448 |
| 85 | JAK1 | 0.80569691 |
| 86 | EPHB1 | 0.80137305 |
| 87 | MAP3K1 | 0.79035313 |
| 88 | PHKG1 | 0.78234109 |
| 89 | PHKG2 | 0.78234109 |
| 90 | LATS2 | 0.77491282 |
| 91 | TESK1 | 0.75994871 |
| 92 | TNK2 | 0.75824850 |
| 93 | MAPK12 | 0.75456838 |
| 94 | PRKD1 | 0.74743401 |
| 95 | MAP2K1 | 0.74285876 |
| 96 | STK38 | 0.73604587 |
| 97 | MAP3K13 | 0.72190699 |
| 98 | STK11 | 0.71547086 |
| 99 | GRK6 | 0.71485181 |
| 100 | RPS6KA2 | 0.70690070 |
| 101 | CSF1R | 0.69787932 |
| 102 | FES | 0.69726433 |
| 103 | JAK2 | 0.67719593 |
| 104 | BRD4 | 0.65979938 |
| 105 | MAPK7 | 0.65072097 |
| 106 | TAOK2 | 0.64921610 |
| 107 | EPHB2 | 0.64819385 |
| 108 | NEK9 | 0.63794188 |
| 109 | RPS6KC1 | 0.63195050 |
| 110 | RPS6KL1 | 0.63195050 |
| 111 | RAF1 | 0.62264774 |
| 112 | BCKDK | 0.62108253 |
| 113 | PAK2 | 0.61282416 |
| 114 | CDK5 | 0.59526050 |
| 115 | MTOR | 0.59103306 |
| 116 | HIPK2 | 0.58495259 |
| 117 | MET | 0.57131919 |
| 118 | MAP3K11 | 0.56258716 |
| 119 | PDK2 | 0.55534697 |
| 120 | SGK494 | 0.55478815 |
| 121 | SGK223 | 0.55478815 |
| 122 | PRKD2 | 0.55381519 |
| 123 | MAP3K8 | 0.54698543 |
| 124 | STK3 | 0.53451773 |
| 125 | FGFR1 | 0.53432170 |
| 126 | IRAK1 | 0.52816747 |
| 127 | MATK | 0.52262285 |
| 128 | CDC42BPA | 0.51549928 |
| 129 | CDK12 | 0.51251385 |
| 130 | TRPM7 | 0.50165841 |
| 131 | WNK1 | 0.48880350 |
| 132 | PRKG2 | 0.48648993 |
| 133 | FYN | 0.48509957 |
| 134 | MARK1 | 0.47844048 |
| 135 | EGFR | 0.47807629 |
| 136 | MST1R | 0.47350132 |
| 137 | ERBB2 | 0.47278650 |
| 138 | CAMKK2 | 0.46556250 |
| 139 | ROCK1 | 0.46169277 |
| 140 | WNK4 | 0.44626591 |
| 141 | KDR | 0.43681619 |
| 142 | FGR | 0.42785908 |
| 143 | DYRK1B | 0.41463834 |
| 144 | CSK | 0.40577137 |
| 145 | GSK3A | 0.40419804 |
| 146 | * SGK1 | 0.40227002 |
| 147 | NEK1 | 0.39876502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.09802187 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.30442113 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.25873852 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.05192486 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94827578 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.93781876 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93610771 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.79982890 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.74466035 |
| 10 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.63793428 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.63472131 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.59776561 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57884997 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 1.51034226 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.47123375 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46499091 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.44629196 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.33050468 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32672701 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.31544037 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28868614 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26638827 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25539616 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24978505 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.24405827 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23844026 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.23063798 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22874591 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.18342910 |
| 30 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.18192710 |
| 31 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.18157525 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.18141611 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.16952639 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16153902 |
| 35 | Insulin resistance_Homo sapiens_hsa04931 | 1.13875176 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13716459 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.13440347 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.12235069 |
| 39 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.11360678 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.10722150 |
| 41 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.10478380 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08213845 |
| 43 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.08138613 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07670390 |
| 45 | Glioma_Homo sapiens_hsa05214 | 1.06788825 |
| 46 | Endocytosis_Homo sapiens_hsa04144 | 1.05537187 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05199388 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05135892 |
| 49 | Renin secretion_Homo sapiens_hsa04924 | 1.05065520 |
| 50 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00863684 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00496875 |
| 52 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.98529061 |
| 53 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98064850 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.96467607 |
| 55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.96087655 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.95996863 |
| 57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.95652645 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.94658125 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.94456933 |
| 60 | Colorectal cancer_Homo sapiens_hsa05210 | 0.94231424 |
| 61 | Focal adhesion_Homo sapiens_hsa04510 | 0.94092048 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.93970040 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.92922432 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92034114 |
| 65 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.90107682 |
| 66 | Prostate cancer_Homo sapiens_hsa05215 | 0.89909045 |
| 67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.89762252 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88956712 |
| 69 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87018825 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86517317 |
| 71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86283248 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.85584706 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85472943 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.85324657 |
| 75 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.84526151 |
| 76 | Measles_Homo sapiens_hsa05162 | 0.83088989 |
| 77 | Influenza A_Homo sapiens_hsa05164 | 0.82133306 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81903753 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81755562 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81718268 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.81178857 |
| 82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80686006 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.80579722 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.80489511 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80314878 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.80235944 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80135345 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79020800 |
| 89 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78549534 |
| 90 | Insulin secretion_Homo sapiens_hsa04911 | 0.77208468 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.76953408 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.76467908 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75494503 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.75307989 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.73849995 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73640701 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72990172 |
| 98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72587240 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71508159 |
| 100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.71329201 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.70643403 |
| 102 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.70568865 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69458645 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68691539 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68462856 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.67704161 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.67684706 |
| 108 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67622399 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66740192 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66502456 |
| 111 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.65957426 |
| 112 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65522254 |
| 113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65454425 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64950009 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64164783 |
| 116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63964906 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.63942892 |
| 118 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63565133 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63535722 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63516041 |
| 121 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63088465 |
| 122 | Pertussis_Homo sapiens_hsa05133 | 0.63048039 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62812072 |
| 124 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.61709098 |
| 125 | Legionellosis_Homo sapiens_hsa05134 | 0.61296193 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61142904 |
| 127 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60916334 |
| 128 | Gap junction_Homo sapiens_hsa04540 | 0.60866359 |
| 129 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.60777160 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.60648171 |
| 131 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60478105 |
| 132 | Long-term depression_Homo sapiens_hsa04730 | 0.59444002 |
| 133 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.59165410 |
| 134 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58566492 |
| 135 | Apoptosis_Homo sapiens_hsa04210 | 0.57580329 |
| 136 | Lysosome_Homo sapiens_hsa04142 | 0.57149414 |
| 137 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56579172 |
| 138 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55404913 |
| 139 | Axon guidance_Homo sapiens_hsa04360 | 0.55373335 |
| 140 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55224647 |
| 141 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55028868 |
| 142 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54228050 |
| 143 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54062223 |
| 144 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52787049 |
| 145 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52406253 |
| 146 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51199116 |
| 147 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50817190 |
| 148 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49395917 |
| 149 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49352285 |
| 150 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49301860 |
| 151 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49189020 |
| 152 | Melanogenesis_Homo sapiens_hsa04916 | 0.48244171 |
| 153 | Morphine addiction_Homo sapiens_hsa05032 | 0.48180602 |
| 154 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46922958 |
| 155 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46802365 |

